2021 Week 17: Johnson & Johnson (NYSE: JNJ)

JNJ

Portfolio Update

The FiveTwenty portfolio received no dividends in the past week.

Past Week Dividend$0
Current Quarter Dividend (Q2 2021)$0
LifeTime Dividend$113.04
Estimated Annual Dividend$1,308.32
Dividend Scorecard

The capital allocation for the week of 04/25/2021 to 05/01/2021 will be used to add to our position in Johnson & Johnson (NYSE: JNJ)

JNJ – Position Update

Since our last check-in on JNJ a mere 3 weeks ago in week 14 of 2021, the company reported Q1 2021 results and raised its quarterly dividend on 04/20/2021. Additionally, the share price has moved higher by 1.05% from $162.83 to $165.52.

Continue reading “2021 Week 17: Johnson & Johnson (NYSE: JNJ)”

2021 Week 14: Johnson & Johnson (NYSE: JNJ)

JNJ

The FiveTwenty portfolio received $28.47 in dividends in the past week. TROW and MDU paid their quarterly dividends during the week.

Past Week Dividend$28.47
Current Quarter Dividend (Q2 2021)$0
LifeTime Dividend$113.04
Estimate Annual Dividend$1,057.28
Dividend Scorecard

The capital allocation for the week of 04/04/2021 to 04/10/2021 will be used to establish a position in Johnson & Johnson (NYSE: JNJ).

JNJ – Company profile

Johnson & Johnson (JNJ) is a multinational corporation that develops, manufactures and sells medical devices, pharmaceutical, and consumer packaged goods. Among JNJ’s well known consumer brands are Band-Aid, Tylenol, Johnson’s Baby products, Neutrogena, Clean & Clear, and Acuvue. Official Site | Wikipedia

Continue reading “2021 Week 14: Johnson & Johnson (NYSE: JNJ)”